TAK-243 for advanced cancers that haven't responded to other treatments
Part of Cancer clinical trials.
This trial tests a new drug called TAK-243 for people with advanced cancers (solid tumors or lymphomas) that have not responded to other treatments. It aims to see if the drug is safe and how well it works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have advanced cancer (solid tumor or lymphoma) that has gotten worse or not responded to other treatments.
- Your cancer can be seen on scans or measured (like a tumor).
- It has been at least 4 weeks since your last cancer treatment (or 2 weeks for palliative radiation).
- Your blood cell counts, kidney function, and liver function are within safe limits (based on blood tests).
- You do not have serious heart or lung problems, or certain other medical conditions.
- You are willing to use effective birth control during and for 4 months after treatment, if applicable.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug (MTI-301) for people with advanced solid tumors that have not responded to other treatments. The goal is to see if the drug is safe and shrinks tumors.
This trial tests a new medication called TAK-188 for people with certain advanced solid tumors that have not responded to standard therapies, including checkpoint inhibitors. It aims to see if TAK-188 can help shrink or control the cancer.
This trial tests TAK-505, an experimental drug, for people with advanced solid tumors including lung, colorectal, stomach, or head and neck cancers. It aims to see if the drug can help when standard treatments are no longer working or aren't suitable.
This trial tests a new drug called JSKN027 for people with advanced solid tumors (cancers that have spread) that have not responded to standard treatments. The goal is to see if the drug is safe and can help shrink tumors.
This trial tests a new drug, LM-2417, for people with advanced solid tumors that have come back or not responded to treatment. The study will see if LM-2417 is safe and effective, possibly as a new option for those who have run out of standard therapies.
This trial tests an experimental drug called TSN084 for people with advanced cancers that have not responded to standard treatments. It aims to see if the drug is safe and how well it works.
Hear when a new Advanced Lymphoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.